The role of dopamine-dependent oxidative stress in the pathogenesis of PD and potential therapies that could modulate this process
Liliane Tenenbaum
Laboratory of Experimental Neurosurgery, Université Libre de Bruxelles, Bruxelles, Belgium
Neuroprotective Gene Therapy for Parkinson's disease
Günther Deuschl
Klinik für Neurologie, Christian-Albrechts-Universität zu Kiel, Kiel, Germany
Deep brain stimulation for Parkinson's disease and movement disorders
To enhance your experience and improve our website, we use cookies. By continuing to browse, you agree to their use. For more details, please see our privacy policy.
